Porton Advanced Partners with T&L Biotechnology – CGT One-Stop Solution Targets Global Cell and Gene Therapy Market
Porton Advanced, a subsidiary of Porton Pharma Solutions, Ltd, announced a strategic partnership with T&L...
T&L Biotechnology
Precision Biotech and T&L Biotechnology Form Partnership to Advance Cell and Gene Therapies
China-based Precision Biotech has announced a strategic partnership with compatriot firm T&L Biotechnology Co., Ltd....
T&L Biotechnology Secures RMB 100 Million in Series A Financing
Beijing-based cell and gene therapy (CGT) developer T&L Biotechnology Co., Ltd has reportedly raised RMB...